The National Human Genome Research Institute supports research and training and career development opportunities in support of its research mission which is to accelerate scientific and medical breakthroughs that improve human health. We do this by driving cutting-edge research, developing new technologies, and studying the impact of genomics on society.

Overview

To apprise the community of research areas that support that mission, NHGRI periodically publishes funding opportunities in the NIH Guide for Grants and Contracts. For your convenience, we have also listed the funding opportunities related to NHGRI on this webpage. NHGRI welcomes innovative investigator-initiated applications and encourages investigators with novel ideas to discuss potential applications with program staff during the concept development stage of the application. If you are considering applying for a Program Announcement with special review (PAR) , a Request for Applications (RFA), or an application that exceeds $500K in direct cost in any one year, we encourage you to review the Guidance to Potential Applicants for NHGRI Support.

NHGRI Funding Opportunities

  • The Electronic Medical Records and Genomics (eMERGE) Genomic Risk Assessment and Management Network – Coordinating Center (U01 Clinical Trial Required)
    RFA-HG-19-015
    Application Due Date(s): August 2, 2019
    Expiration Date: August 3, 2019

     
  • The Electronic Medical Records and Genomics (eMERGE) Genomic Risk Assessment and Management Network – Enhanced Diversity Clinical Sites (U01 Clinical Trial Required)
    RFA-HG-19-014
    Application Due Date(s): August 2, 2019
    Expiration Date: August 3, 2019

     
  • The Electronic Medical Records and Genomics (eMERGE) Genomic Risk Assessment and Management Network – Clinical Sites(U01 Clinical Trial Required) 
    RFA-HG-19-013
    Application Due Date(s): August 2, 2019
    Expiration Date: August 3, 2019

     
  • Notice Announcing the National Human Genome Research Institute's Genomics in Medicine and Health Strategic Planning Workshop
    NOT-HG-19-020
    Expiration Date: May 11, 2019
     
  • Investigator-Initiated Genomic Medicine Research (R01 Clinical Trial Optional)
    PAR-18-735
    Application Due Date(s): June 20, 2018; October 19, 2018; June 20, 2019; October 21, 2019; June 19, 2020; October 20, 2020
    Expiration Date: January 23, 2021
     
  • Investigator-Initiated Genomic Medicine Research (R21 Clinical Trial Optional)
    PAR-18-736
    Application Due Date(s): June 20, 2018; October 19, 2018; June 20, 2019; October 21, 2019; June 19, 2020; October 20, 2020
    Expiration Date: January 23, 2021
     
  • Notice of Availability of Administrative Supplements for Short-term Research Career Enhancement in Genomics for Experienced Investigators
    NOT-HG-19-019
     
  • Limited Competition Centers of Excellence in Ethical, Legal and Social Implications (ELSI) Research (CEER) (RM1 Clinical Trial Optional) 
    RFA-HG-19-012
    Application Due Date(s): July 23, 2019
    Expiration Date: July 24, 2019

     
  • Genomic Innovator Award (R35 Clinical Trial Optional) 
    RFA-HG-18-006 
    Application Due Dates: October 30, 2018; October 30, 2019; October 30, 2020
    Expiration Date: October 31, 2020
     
  • Novel Approaches for Relating Genetic Variation to Function and Disease (R21 Clinical Trial Not Allowed) 
    PAR-18-867
    Application Due Dates: February 16, June 16, October 16
    Expiration Date: July 17, 2021

     
  • Novel Approaches for Relating Genetic Variation to Function and Disease (R01 Clinical Trial Not Allowed) 
    PAR-18-868
    Application Due Dates: February 5, June 5, October 5
    Expiration Date: July 6, 2021

     
  • Investigator Initiated Research in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed) 
    PAR-18-843 
    Application Due Date(s): November 16, 2018; July 16, 2019; November 16, 2019; July 16, 2020; November 16, 2020; July 16, 2021?
    Expiration Date: September 8, 2021

     
  • Investigator Initiated Research in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)  
    PAR-18-844
    Application Due Date(s): November 16, 2018; July 16, 2019; November 16, 2019; July 16, 2020; November 16, 2020; July 16, 2021
    Expiration Date: September 8, 2021

     
  • Novel Genomic Technology Development (R01 Clinical Trial Not Allowed) 
    PAR-18-777 
    Application Due Date(s): October 2, 2018; October 2, 2019; October 2, 2020
    Expiration Date: January 8, 2021
  • Novel Genomic Technology Development (R43/R44 Clinical Trial Not Allowed) 
    PAR-18-779  
    Application Due Date(s): October 2, 2018; October 2, 2019; October 2, 2020
    Expiration Date: January 8, 2021

  • Novel Genomic Technology Development (R21 Clinical Trial Not Allowed) 
    PAR-18-778
    Application Due Date(s): October 2, 2018; October 2, 2019; October 2, 2020
    Expiration Date: January 8, 2021

  • Novel Nucleic Acid Sequencing Technology Development (R01 Clinical Trial Not Allowed)
    RFA-HG-18-001
    Application Due Date(s): June 27, 2018; June 27, 2019; June 26, 2020
    Expiration Date: September 11, 2020

  • Novel Nucleic Acid Sequencing Technology Development (R21 Clinical Trial Not Allowed)
    RFA-HG-18-002 
    Application Due Date(s): June 27, 2018; June 27, 2019; June 26, 2020
    Expiration Date: September 11, 2020

  • Novel Nucleic Acid Sequencing Technology Development (R43/R44 Clinical Trial Not Allowed)
    RFA-HG-18-003 
    Application Due Date(s): June 27, 2018; June 27, 2019; June 26, 2020
    Expiration Date: September 11, 2020

  • Comparative Genomics Research Program (R01-Clinical Trial Not Allowed)
    PAR-17-482 
    Application Due Date(s): February 5, June 5, October 5
    Expiration Date: January 8, 2021

     
  • Ethical, Legal, and Social Implications (ELSI) of Genomic Research Regular Research Program (R01) 
    PA-17-325 
    Application Receipt Date(s): Standard dates apply
    Expiration Date: September 8, 2020
     
  • Ethical, Legal, and Social Implications (ELSI) of Genomic Research Small Research Grant Program (R03) 
    PA-17-324 
    Application Receipt Date(s): Standard dates apply
    Expiration Date: September 8, 2020
     
  • Ethical, Legal, and Social Implications (ELSI) of Genomic Research Exploratory/Developmental Research Grant Program (R21) 
    PA-17-323 
    Application Receipt Date(s): Standard dates apply
    Expiration Date: September 8, 2020
     
  • Genomic Community Resources (U24)
    PAR-17-273 
    Application Due Date(s): First due date is July 13, 2017; Standard dates apply after that, by 5:00 PM local time of applicant organization.
    Expiration Date: January 20, 2020

     
  • Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01)
    PAR-17-269 
    Application Due Date(s): Applications are accepted by continuous receipt by 5:00 PM local time of applicant organization.
    Expiration Date: July 11, 2020

     
  • Centers of Excellence in Genomic Science (CEGS) (RM1)
    PAR-16-436 
    Application Due Date(s): May 23, 2017; May 21, 2018; May 20, 2019
    Expiration Date: May 21, 2019

     
  • Genomics of HIV/AIDS Drug Response and Co-Morbidities (R01)
    PAR-16-435
    Application Due Date(s): Not Applicable
    Expiration Date: May 8, 2020

     
  • Technology and Methods Development for Genomics, Population Genomics and ELSI
    PA-07-458

NIH-Wide Parent Funding Opportunities

  • PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
    PA-19-272
     
  • PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
    PA-19-273
     
  • PHS 2019-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)
    PA-19-270
     
  • PHS 2019-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)
    PA-19-271 
     
  • NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
    PA-19-052
  • NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) 
    PA-18-648 
    Application Due Date(s): April 12, August 12, December 12
    Expiration Date: January 8, 2021

  • Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Admin Supp)
    PA-18-591 
    Application Receipt Date(s): Multiple dates, see announcement.
    Expiration Date: January 26, 2021

    Administrative Supplements - NHGRI Guidance

  • Academic Research Enhancement Award (Parent R15 Clinical Trial Not Allowed)
    PA-18-504 
    Application Due Date(s): February 25, June 25, October 25
    Expiration Date: January 8, 2021

     
  • NIH Research Project Grant (Parent R01 Clinical Trial Required) 
    PA-18-345
    Application Receipt Date(s): February 5, June 5, October 5
    Expiration Date: January 8, 2021

     
    • Companion Funding Opportunity:
      PA-18-484 - NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
       
  • NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required) 
    PA-18-344 
    Application Receipt Date(s): February 16, June 16, October 16
    Expiration Date: January 8, 2021

     
    • Companion Funding Opportunity:
      PA-18-489 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
       
  • Research on the Health of Transgender and Gender Nonconforming Populations (R21) 
    PA-17-477 
    Application Receipt Date(s): February 16, June 16, October 16
    Expiration Date: September 8, 2020

     
  • Research on the Health of Transgender and Gender Nonconforming Populations (R01) 
    PA-17-478 
    Application Receipt Date(s): February 5, June 5, October 5
    Expiration Date: September 8, 2020

     
  • Change of Grantee Organization (Type 7 Parent)
    PA-16-285 
    Application Receipt Date(s): A change of grantee organization request must be made before the anticipated start date at the new organization and preferably several months in advance.
    Expiration Date: May 26, 2019

     
  • Successor-in-Interest (Type 6 Parent)
    PA-16-286 
    Application Receipt Date(s): A change of grantee organization request must be made before the anticipated start date at the new organization and preferably several months in advance.
    Expiration Date: May 26, 2019

NIH-Wide Topic Specific Funding Opportunities

  • Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
    PAR-19-274
    Application Receipt/Submission Date(s): February 5, June 5, October 5
    Expiration Date: May 8, 2022

  • Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
    PAR-19-275
    Application Receipt/Submission Date(s): February 16, June 16, October 16
    Expiration Date: May 8, 2022

  • Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
    PAR-19-276
    Application Receipt/Submission Date(s): February 16, June 16, October 16
    Expiration Date: May 8, 2022

  • Notice of Special Interest for Administrative Supplements for Research on Sexual and Gender Minority (SGM) Populations (Admin Supp Clinical Trial Optional)
    NOT-OD-19-102

  • International Bioethics Research Training Program (D43 Clinical Trial Optional)
    PAR-19-243
    Application Receipt/Submission Date(s): June 4, 2019; June 4, 2020, June 4, 2021
    Expiration Date: June 5, 2021

  • International Research Ethics Education and Curriculum Development Award (R25 Clinical Trial Not Allowed)
    PAR-19-244
    Application Receipt/Submission Date(s): June 4, 2019, June 4, 2020, June 4, 2021
    Expiration Date: June 5, 2021

  • Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations An ORWH FY19 Administrative Supplement (Admin Supp Clinical Trial Optional)
    PA-19-205 
    Application Due Date(s): April 8, 2019
    Expiration Date: April 9, 2019

  • NIH Highlights Support for Data Science Research through the Academic Research Enhancement Award (AREA) Program
    NOT-GM-19-021 
     
  • Notice of Special Interest in Research on the Health of Sexual and Gender Minority (SGM) Populations
    NOT-MD-19-001 
     
  • Administrative Supplement for Research on Bioethical Issues (Admin Supp Clinical Trial Optional)
    PA-19-217 
    Application Due Date(s): May 13, 2019
    Expiration Date: May 14, 2019
     
  • National Science Foundation - National Institutes of Health NSF-NIH Interagency Initiative: Smart and Connected Health
    NOT-OD-18-149 
  • Academic Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Not Allowed) 
    PAR-18-714 
    Application Due Date: February 25, June 25, October 25
    Expiration Date: May 8, 2021

  • Research on the Health of Transgender and Gender Nonconforming Populations (R21 Clinical Trial Optional) 
    PA-18-728 
    Application Due Date(s): February 16, June 16, October 16
    Expiration Date: January 8, 2021 

     
  • Research on the Health of Transgender and Gender Nonconforming Populations (R01 Clinical Trial Optional) 
    PA-18-729 
    Application Due Date(s): February 5, June 5, October 5
    Expiration Date: January 8, 2021 

     
  • National Science Foundation - National Institutes of Health NSF-NIH Interagency Initiative: Smart and Connected Health 
    NOT-OD-18-149 
     
  • Announcing the High-Priority, Short-Term Project Award (R56) 
    • Notice of NHGRI's Participation in NOT-OD-04-047 "High Priority, Short-Term Project Award (R56)" 
      NOT-HG-17-004 [grants.nih.gov]
       
  • Notice of NHGRI Participation in PAR-15-287 "Opportunities for Collaborative Research at the NIH Clinical Center (U01)"
    NOT-OD-04-047
     
  • Notice of Interest in High Priority Research in Bioethical, Legal, and Societal Implications of Biomedical Research 
    NOT-LM-17-001
     
  • Notice of NIH/BD2K Participation in the Joint NSF/NIH Initiative on Quantitative Approaches to Biomedical Big Data (QuBBD) 
    NOT-EB-16-008
     
  • Serious Adverse Drug Reaction Research (R01)
    PAR-16-275
    Application Due Dates: October 4, 2016; February 1, 2017; June 1, 2017; October 2, 2017; February 1, 2018; June 1, 2018; October 1, 2018; February 1, 2019; June 3, 2019
    Expiration Date: September 8, 2019

     
  • Serious Adverse Drug Reaction Research (R21)
    PAR-16-274 
    Application Due Dates: October 4, 2016; February 1, 2017; June 1, 2017; October 2, 2017; February 1, 2018; June 1, 2018; October 1, 2018; February 1, 2019; June 3, 2019
    Expiration Date: September 8, 2019

     
  • Dissemination and Implementation Research in Health (R21)
    PAR-16-236 
    Application Due Dates: February 16, June 16, October 16
    Expiration Date: May 8, 2019

     
  • Dissemination and Implementation Research in Health (R03)
    PAR-16-237 
    Application Due Dates: February 16, June 16, October 16
    Expiration Date: May 8, 2019

     
  • Dissemination and Implementation Research in Health (R01)
    PAR-16-238 
    Application Due Dates: February 5, June 5, October 5
    Expiration Date: May 8, 2019

     
  • Tools for Cell Line Identifcation (SBIR [R43/R44])
    PA-16-186 
    Application Due Dates: September 5, January 5, April 5
    Expiration Date: April 6, 2019

     
  • Notice of Information: Parallel Funding Initiative for Collaborative Research Between Investigators in the USA and in the State of São Paulo, Brazil 
    NOT-TW-16-001

Last updated: May 23, 2019